文献速递皮肤肿瘤

局限性黑色素瘤近期切除后患者对随访的偏好

Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma.
PubMed 文献 · JAMA Dermatol · 2018-01-01

这项电话调查研究在澳大利亚专科中心随机邀请400例2014年完成局限性黑色素瘤治疗的患者,询问其对标准与减少门诊随访频率的偏好。262人同意受访,230例无复发或新原发黑色素瘤者中149人偏好标准随访、81人偏好减少随访(调整抽样框后70% vs 30%)。仅8%错过预约,40%未做皮肤自查或间隔超过3个月。

要点

  • 230例无复发或新原发黑色素瘤者中,149人偏好标准随访、81人偏好减少随访(调整后70% vs 30%)。
  • 偏好减少随访的独立相关因素包括更高疾病分期、四肢黑色素瘤、与他人同住、无私人医疗保险及因其他慢性病就诊专科。
  • 复发或新原发黑色素瘤首次发现到治疗的中位延迟分别为7周和3周。

核心结论

  • 部分黑色素瘤患者若得到皮肤自查支持并能对任何担忧获得快速临床评估(患者主导监测),可能偏好减少门诊随访。

研究设计与样本

  • 电话调查研究,在澳大利亚一家专科中心随机邀请400例2014年完成局限性黑色素瘤治疗的患者,262人同意受访。

主要发现

  • 262例受访者平均(SD)年龄64.3(14.3)岁,93人(36%)为女性。
  • 230例无复发或新原发黑色素瘤者中,149人偏好标准随访、81人偏好减少随访(调整抽样框后70% vs 30%)。
  • 复发或新原发黑色素瘤首次发现到治疗的中位延迟分别为7周和3周。
  • 仅8%错过预约,40%未做皮肤自查或间隔超过3个月。

关键数值与推荐

  • 标准随访频率按澳大利亚指南推荐,减少随访频率改编自黑色素瘤随访(MELFO)减少随访研究。

临床怎么用

  • 部分患者可能偏好减少门诊随访,前提是支持其进行皮肤自查并对任何担忧快速临床评估(患者主导监测)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The standard model of follow-up posttreatment of localized melanoma relies on clinician detection of recurrent or new melanoma, through routinely scheduled clinics (clinician-led surveillance). An alternative model is to increase reliance on patient detection of melanoma, with fewer scheduled visits and increased support for patients' skin self-examination (SSE) (eg, using smartphone apps to instruct, prompt and record SSE, and facilitate teledermatology; patient-led surveillance). OBJECTIVE: To determine the proportion of adults treated for localized melanoma who prefer the standard scheduled visit frequency (as per Australian guideline recommendations) or fewer scheduled visits (adapted from the Melanoma Follow-up [MELFO] study of reduced follow-up). DESIGN, SETTING, AND PARTICIPANTS: This survey study used a telephone interview for surveillance following excision of localized melanoma at an Australian specialist center. We invited a random sample of 400 patients who had completed treatment for localized melanoma in 2014 to participate. They were asked about their preferences for scheduled follow-up, and experience of follow-up in the past 12 months. Those with a recurrent or new primary melanoma diagnosed by the time of interview (0.8-1.7 years since first diagnosis) were asked about how it was first detected and treated. SSE practices were also assessed. MAIN OUTCOMES AND MEASURES: Proportion preferring standard vs fewer scheduled clinic visits, median delay between detection and treatment of recurrent or new primary melanoma, and SSE practices. RESULTS: Of the 262 people who agreed to be interviewed, the mean (SD) age was 64.3 (14.3) years, and 93 (36%) were women. Among the 230 people who did not have a recurrent or new primary melanoma, 149 vs 81 preferred the standard vs fewer scheduled clinic visits option (70% vs 30% after adjusting for sampling frame). Factors independently associated with preferring fewer visits were a higher disease stage, melanoma on a limb, living with others, not having private health insurance, and seeing a specialist for another chronic condition. The median delay between first detection and treatment of recurrent or new primary melanoma was 7 and 3 weeks, respectively. Only 8% missed a scheduled visit, while 40% did not perform SSE or did so at greater than 3-month intervals. CONCLUSIONS AND RELEVANCE: Some patients with melanoma may prefer fewer scheduled visits, if they are supported to do SSE and there is rapid clinical review of anything causing concern (patient-led surveillance).

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Lim WY, Morton RL, Turner RM, et al. Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma. JAMA Dermatol. 2018. PMID: 29490373. doi:10.1001/jamadermatol.2018.0021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。